Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human somatic gene therapy: progress and problems

M K Brenner1

  • 1Division of Bone Marrow Transplantation, St Jude Childrens' Research Hospital, Memphis, Tennessee.

Journal of Internal Medicine
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

A whole blood model of thrombocytopenia that controls platelet count and hematocrit.

Annals of hematology·2016
Same author

Delayed Induction of Proto-Oncogene Expression in B-CLL Cells by Tumor Necrosis Factor.

Leukemia & lymphoma·2016
Same author

Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD.

Bone marrow transplantation·2014
Same author

Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma.

Bone marrow transplantation·2013
Same author

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals.

Gene therapy·2013

Gene therapy shows promise but faces vector limitations. Research into gene transfer into hematopoietic stem cells (HSC) is advancing treatments for various diseases.

Area of Science:

  • Molecular Biology
  • Genetics
  • Medical Biotechnology

Background:

  • Gene therapy holds significant potential but is limited by current vector capabilities for safe, targeted, and regulated gene transfer.
  • Over 65 clinical gene transfer protocols are approved in the US, primarily for malignant diseases where the risk-benefit ratio is favorable.

Purpose of the Study:

  • To review progress and challenges in gene transfer, focusing on hematopoietic stem cells (HSC).
  • To highlight the importance of HSC for treating a wide range of pathologies.
  • To discuss the use of marker genes in HSC studies to improve gene transfer efficiency and expression.

Main Methods:

  • Review of current gene transfer technologies and clinical applications.
  • Focus on studies involving gene transfer into hematopoietic stem cells (HSC).

Related Experiment Videos

  • Analysis of marker gene transfer to understand efficiency and conditions for enhanced gene transfer and expression in hematopoietic tissue.

    • Main Results:

    • Initial studies using marker genes in HSC have provided insights into gene transfer efficiency and expression.
    • Information from these studies is guiding improvements in autologous and allogeneic marrow transplantation.
    • Gene transfer research has contributed to developing gene therapy protocols for cancers, immune deficiencies, and lysosomal storage disorders.

    Conclusions:

    • Despite vector limitations, gene transfer into HSC is a key area of research with broad therapeutic potential.
    • Advancements in gene transfer technology are expected to lead to numerous new clinical applications in the coming decade.
    • Ongoing research in gene transfer into HSC is crucial for developing effective treatments for genetic and acquired diseases.